Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City
Cancer Network,
INTRODUCTION In 2022, prostate cancer was estimated to be the most diagnosed malignancy among men in Mexico, accounting for 26,56…